This NIH Funding Opportunity Announcement (FOA) is part of the Stimulating Peripheral Activity to Relieve Conditions (SPARC) Common Fund program.
This FOA invites applications exclusively for non-clinical tests in animal models to obtain safety and efficacy data that support new market indications
for a limited set of neuromodulation devices.
Partnering companies (see Device Portal) have agreed to provide neuromodulation technology to investigators supported by the SPARC program.
Pre-clinical developments supported by this FOA are expected to generate the necessary safety and efficacy evidence to enable an Investigational Device Exemption (IDE) submission for a future pilot clinical study.